Sarepta Therapeutics Inc
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of SRPT would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1997) — listing | $37,326 0.9× | $54,255 0.9× |
| Year 6 (2002) | $33,808 0.9× | $49,136 0.9× |
| Year 11 (2007) | $27,583 0.9× | $40,141 0.9× |
| Year 16 (2012) | $11,955 0.6× | $17,520 0.6× |
| Year 21 (2017) | $3,923 0.3× | $5,726 0.3× |
| Year 26 (2022) | $2,203 0.3× | $3,218 0.3× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Cambridge, Massachusetts, United States
Popular scenarios with SRPT
For illustration only — not investment advice. Past performance is not indicative of future results.